Jeryl L Hilleman
CIK 1216628 · View on SEC EDGAR ↗
First SEC filing: June 9, 2026 · Latest: June 9, 2026
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 2, 2026 | NVCR | S | 2,945 | $15.77 | $46,443 | 13,861 Direct | -17.52% | Disposed | 10.4% (price as of 2026-08-21) |
| June 26, 2019 | NERV | P | 1,000 | $5.25 | $5,250 | 1,000 Direct | — | Acquired | -88.2% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 3, 2026 | NVCR | Stock Option (Right to Buy) | Ordinary Shares (16,999) | $16.15 | June 3, 2036 | 16,999 | Acquired |
| Sept. 27, 2023 | NERV | Stock Option (right to buy) [F1] | Common Stock (12,500) | $7.30 | Sept. 26, 2033 | 12,500 | Acquired |
| June 10, 2022 | NERV | Stock Option (right to buy) [F1] | Common Stock | — | June 9, 2032 | 2,500 | Acquired |
| June 11, 2021 | NERV | Stock Option (right to buy) [F1] | Common Stock (20,000) | $2.90 | June 10, 2031 | 20,000 | Acquired |
| June 11, 2020 | NERV | Stock Option (right to buy) [F1] | Common Stock (20,000) | $3.40 | June 10, 2030 | 20,000 | Acquired |
| May 31, 2019 | NERV | Stock Option (right to buy) | Common Stock (20,000) | $5.21 | May 30, 2029 | 20,000 | Acquired |
| May 22, 2019 | NVCR | Options to Buy Ordinary Shares | Ordinary Shares (6,340) | $51.36 | May 22, 2029 | 6,340 | Acquired |
| July 31, 2018 | NVCR | Options to Buy Ordinary Shares | Ordinary Shares (37,101) | $34.00 | July 30, 2028 | 37,101 | Acquired |
| July 16, 2018 | NERV | Stock Option (Right to Buy) | Common Stock (40,000) | $8.20 | July 16, 2028 | 40,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 8 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| June 5, 2025 | OMDA | Stock Option (Right to Buy)→ Common Stock | — | Direct |
| June 5, 2025 | OMDA | Stock Option (Right to Buy)→ Common Stock | — | Direct |
| June 5, 2025 | OMDA | Stock Option (Right to Buy)→ Common Stock | — | Direct |
| June 5, 2025 | OMDA | Stock Option (Right to Buy)→ Common Stock | — | Direct |
| June 5, 2025 | OMDA | Stock Option (Right to Buy)→ Common Stock | — | Direct |
| June 5, 2025 | OMDA | Stock Option (Right to Buy)→ Common Stock | — | Direct |
| Dec. 4, 2019 | SIBN | No securities are beneficially owned | 0 | Direct |
| Aug. 6, 2018 | NVCR | Option to Buy Ordinary Shares→ Ordinary Shares (37,101) | 37,101 | Direct |